SCHEMBL30853451

SCHEMBL30853451

Clc1ccccc1OCc1ccccn1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 7/20 0.67
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
MAPT P10636 1/20 0.58
CYP2C9 P11712 1/20 0.58
HPGD P15428 1/20 0.58
CYP2C19 P33261 1/20 0.58
CASP3 P42574 1/20 0.58
SENP8 Q96LD8 1/20 0.58
SENP7 Q9BQF6 1/20 0.58
SENP6 Q9GZR1 1/20 0.58
FFAR1 O14842 1/20 0.56
ABCB1 P08183 1/20 0.55
HTR1A P08908 1/20 0.55
DRD2 P14416 1/20 0.55
AURKB Q96GD4 3/20 0.53
INCENP Q9NQS7 3/20 0.53
TP53 P04637 3/20 0.51
NPC1 O15118 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4342702 1.00 SYK (0.67) SYKCYP1A2CYP3A4CYP2D6MAPT
Ammonia Solution, Strong SCHEMBL4267568 0.98 SYK (0.65) SYKCYP1A2CYP3A4CYP2D6MAPT
Hydrochloric Acid SCHEMBL27878170 0.96 SYK (0.63) SYKCYP1A2CYP3A4CYP2D6MAPT
SCHEMBL29568574 0.82 SYK (0.58) SYKCYP1A2CYP3A4CYP2D6MAPT
SCHEMBL21340419 0.82 SYK (0.58) SYKCYP1A2CYP3A4CYP2D6MAPT
SCHEMBL29638125 0.80 SYK (0.78) SYKABCB1HTR1ADRD2AURKB
SCHEMBL29989288 0.80 SYK (0.57) SYKMAPTABCB1HTR1ADRD2
SCHEMBL17385133 0.80 SYK (0.57) SYKMAPTABCB1HTR1ADRD2
SCHEMBL2760112 0.80 SYK (0.59) SYKCYP1A2CYP3A4MAPTCYP2C9
SCHEMBL159323 0.80 SYK (0.78) SYKABCB1HTR1ADRD2AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112679473-B Lenatinib intermediate crystal, preparation method and application thereof 四川科伦药物研究院有限公司 2024-03-05 CN disclosed